JP2012528830A5 - - Google Patents

Download PDF

Info

Publication number
JP2012528830A5
JP2012528830A5 JP2012513621A JP2012513621A JP2012528830A5 JP 2012528830 A5 JP2012528830 A5 JP 2012528830A5 JP 2012513621 A JP2012513621 A JP 2012513621A JP 2012513621 A JP2012513621 A JP 2012513621A JP 2012528830 A5 JP2012528830 A5 JP 2012528830A5
Authority
JP
Japan
Prior art keywords
range
adrenergic compound
compound
pharmaceutical composition
antioxidant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012513621A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012528830A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/057771 external-priority patent/WO2010139751A2/en
Publication of JP2012528830A publication Critical patent/JP2012528830A/ja
Publication of JP2012528830A5 publication Critical patent/JP2012528830A5/ja
Pending legal-status Critical Current

Links

JP2012513621A 2009-06-04 2010-06-03 少なくとも1つのアドレナリン作動性化合物を含む安定化された組成物 Pending JP2012528830A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18406609P 2009-06-04 2009-06-04
DKPA200900705 2009-06-04
US61/184,066 2009-06-04
DKPA200900705 2009-06-04
PCT/EP2010/057771 WO2010139751A2 (en) 2009-06-04 2010-06-03 Stabilised composition comprising at least one adrenergic compound

Publications (2)

Publication Number Publication Date
JP2012528830A JP2012528830A (ja) 2012-11-15
JP2012528830A5 true JP2012528830A5 (cg-RX-API-DMAC7.html) 2013-07-11

Family

ID=41364279

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012513621A Pending JP2012528830A (ja) 2009-06-04 2010-06-03 少なくとも1つのアドレナリン作動性化合物を含む安定化された組成物
JP2012513622A Expired - Fee Related JP6087145B2 (ja) 2009-06-04 2010-06-03 少なくとも1つのアドレナリン作動性化合物を含む安定化された組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012513622A Expired - Fee Related JP6087145B2 (ja) 2009-06-04 2010-06-03 少なくとも1つのアドレナリン作動性化合物を含む安定化された組成物

Country Status (15)

Country Link
US (1) US9155694B2 (cg-RX-API-DMAC7.html)
EP (2) EP2437782B1 (cg-RX-API-DMAC7.html)
JP (2) JP2012528830A (cg-RX-API-DMAC7.html)
KR (2) KR20120028344A (cg-RX-API-DMAC7.html)
CN (3) CN102802668A (cg-RX-API-DMAC7.html)
AU (2) AU2010255748B2 (cg-RX-API-DMAC7.html)
BR (2) BRPI1013019A2 (cg-RX-API-DMAC7.html)
CA (2) CA2764051A1 (cg-RX-API-DMAC7.html)
DK (2) DK2437781T3 (cg-RX-API-DMAC7.html)
ES (2) ES2432164T3 (cg-RX-API-DMAC7.html)
MX (2) MX2011012732A (cg-RX-API-DMAC7.html)
PT (2) PT2437782E (cg-RX-API-DMAC7.html)
RU (2) RU2527680C2 (cg-RX-API-DMAC7.html)
SI (2) SI2437782T1 (cg-RX-API-DMAC7.html)
WO (2) WO2010139752A2 (cg-RX-API-DMAC7.html)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8628805B2 (en) * 2009-06-04 2014-01-14 Alk Ag Stabilized composition comprising at least one adrenergic compound
CN102525894A (zh) * 2012-01-04 2012-07-04 上海禾丰制药有限公司 盐酸异丙肾上腺素注射液及其制剂工艺
CN102525893B (zh) * 2012-01-04 2013-11-20 上海禾丰制药有限公司 盐酸去氧肾上腺素注射液及其制剂工艺
AU2013328393A1 (en) * 2012-10-08 2015-04-09 Wockhardt Limited Stable injectable pharmaceutical composition of epinephrine or salts thereof
TWI780236B (zh) * 2013-02-04 2022-10-11 法商賽諾菲公司 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
US12239822B2 (en) 2013-03-15 2025-03-04 Windgap Medical, Inc. Portable drug mixing and delivery device and associated methods
US20150231334A1 (en) * 2013-12-18 2015-08-20 Windgap Medical, Inc. Drug mixing and delivery system and method
BR112016007328A2 (pt) 2013-10-03 2017-08-01 Imprimis Pharmaceuticals Inc composições oftálmicas baseadas em epinefrina para administração intraocular e métodos para fabricar as mesmas
US12702651B2 (en) 2013-10-03 2026-08-11 Harrow Ip, Llc Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
CN103520096B (zh) * 2013-10-25 2015-02-25 成都晶博生物科技有限责任公司 一种硫酸特布他林注射液的生产工艺
JP6641280B2 (ja) 2014-01-09 2020-02-05 サノフイSanofi インスリンアナログおよび/またはインスリン誘導体の安定化された医薬製剤
UY35988A (es) * 2014-02-27 2015-09-30 Sint Sa Proceso para la producción de una solución inyectable de noradrenalina de baja concentración
PL2990031T3 (pl) 2014-08-28 2020-05-18 Sun Pharmaceutical Industries Ltd Pozajelitowa postać norepinefryny
CN107205938A (zh) * 2014-12-18 2017-09-26 温德加普医疗股份有限公司 用于溶解或增溶治疗剂的方法和组合物
US20170189352A1 (en) 2015-03-13 2017-07-06 Par Pharmaceutical, Inc. Epinephrine formulations
US9119876B1 (en) * 2015-03-13 2015-09-01 Par Pharmaceutical, Inc. Epinephrine formulations
US10039710B2 (en) * 2015-09-18 2018-08-07 Insys Development Company, Inc. Epinephrine spray formulations
US11517525B2 (en) * 2015-09-18 2022-12-06 Hikma Pharmaceuticals Usa Inc. Epinephrine spray formulations
WO2018039420A1 (en) * 2016-08-25 2018-03-01 Imprimis Pharmaceuticals, Inc. Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
RU2635759C1 (ru) * 2016-09-13 2017-11-15 Интеллег Сосьете Анониме Фармацевтическая композиция для парентерального введения и способ ее получения
US10835503B2 (en) 2017-01-13 2020-11-17 Teva Pharmaceuticals Usa, Inc. Pre-filled syringe
WO2018140894A1 (en) 2017-01-30 2018-08-02 Nevakar, Inc Norepinephrine compositions and methods therefor
US20250177328A1 (en) 2017-01-30 2025-06-05 Nevakar Injectables Inc. Norepinephrine compositions and methods therefor
EP3612173B1 (en) * 2017-04-17 2023-10-11 Hikma Pharmaceuticals USA Inc. Epinephrine spray formulations
EP3687475A4 (en) * 2017-09-26 2021-07-28 YS Pharmtech STABILIZATION OF EPINEPHRIN FORMULATIONS
JP2020536926A (ja) 2017-10-10 2020-12-17 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung L−エピネフリンの安定化注射用医薬用組成物
WO2019182745A1 (en) 2018-03-19 2019-09-26 Bryn Pharma, LLC Epinephrine spray formulations
CA3093725C (en) 2018-03-23 2021-08-24 Nevakar Inc. Epinephrine compositions and containers
US10952962B1 (en) 2018-04-11 2021-03-23 QuVa Pharma, Inc. Ready to use liquid formulation
CA3096684A1 (en) 2018-04-11 2019-10-17 Travis A. Leeah Ready-to-use liquid reck formulation
US10478406B2 (en) 2019-03-18 2019-11-19 HARC Therapeutics AG High-pH solid-state epinephrine formulation
CN116474218A (zh) * 2019-06-28 2023-07-25 四川普锐特药业有限公司 保持给药均一度的药物流体分配器及右美托咪定鼻喷器
CN114286669A (zh) * 2019-08-08 2022-04-05 太阳医药工业有限公司 去甲肾上腺素的输注剂型
USD1004518S1 (en) 2019-09-09 2023-11-14 Brunswick Corporation Railing for a marine vessel
CA3174640A1 (en) * 2020-03-06 2021-09-10 Baxter International Inc. Packaged, sealed container system for stable storage of an oxygen sensitive pharmaceutical formulation
USD984953S1 (en) 2021-05-03 2023-05-02 Brunswick Corporation Safely railing having buoy holder
AU2021203856B2 (en) * 2021-06-10 2023-03-09 Animal Ethics Pty Ltd Topical anaesthetic composition having improved vasoconstrictor stability
EP4547232A4 (en) * 2022-08-27 2025-10-08 Biophore India Pharmaceuticals Pvt Ltd TRIENTINE LIQUID DOSAGE FORMS

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB425678A (en) 1933-06-15 1935-03-15 Novocol Chemical Mfg Co Inc Improvements relating to anesthetics for hypodermic injection
US2047144A (en) * 1934-03-26 1936-07-07 Lilly Co Eli Stabilized epinephrine-type compound, and process of stabilizing it
US2382546A (en) * 1941-11-03 1945-08-14 Curtis David Anesthetic solutions
BE617022A (cg-RX-API-DMAC7.html) * 1961-04-28
US3419035A (en) * 1965-05-25 1968-12-31 Badger Meter Mfg Co Air elimination device for liquid transport system
CA981182A (en) 1972-01-07 1976-01-06 Walter A. Borisenok Stabilization of 1-epinephrine in local anesthetic solutions with a combination of three antioxidants
US3966905A (en) 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
DD150694A1 (de) 1980-04-16 1981-09-16 Gisela Raether Verfahren zur stabilisierung von pharmazeutischen praeparaten mit oxidationsempfindlichen bestandteilen
US4734438A (en) 1983-04-26 1988-03-29 Macri Frank J Norepinephrine potentiated compositions and method of use
WO1994013274A1 (en) 1992-12-10 1994-06-23 Abbott Laboratories Stabilized catecholamine solutions
JP3535537B2 (ja) * 1993-04-15 2004-06-07 日本製薬株式会社 静脈注射剤
US6077545A (en) 1995-10-30 2000-06-20 Matrix Pharmaceuticals, Inc. Process and composition for therapeutic cisplatin (CDDP)
JP2001505197A (ja) 1996-11-14 2001-04-17 アルザ・コーポレーション リドカイン及びエピネフリンの電気的補助投与のための製剤
CA2265767C (en) 1997-07-11 2007-12-04 Nobuyuki Hanamura Stable pharmaceutical composition including 4,5-epoxy-morphinan derivative
JP4393641B2 (ja) 1998-11-26 2010-01-06 久光製薬株式会社 イオントフォレーシス用粘着ゲル組成物及びその装置
EP1326642A2 (en) 2000-09-29 2003-07-16 Board of Trustees operating Michigan State University Catecholamine pharmaceutical compositions and methods
CN100522998C (zh) 2003-10-01 2009-08-05 协和发酵麒麟株式会社 抗体的稳定化方法和被稳定的溶液状抗体制剂
UA71839C2 (uk) 2003-12-30 2007-06-25 Товариство З Обмеженою Відповідальністю "Фарм-Стом" Фармацевтична композиція на основі артикаїну та епінефрину
US20050228336A1 (en) 2004-04-07 2005-10-13 Preston Keusch Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
US20060129122A1 (en) 2004-12-06 2006-06-15 Wyrick Ronald E Method and apparatus for delivering epinephrine
NZ571537A (en) 2006-04-03 2012-06-29 Nutramax Lab Inc Stabilized pentosan polysulfate (PPS) formulations and methods of analayzing them
US20070249727A1 (en) * 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US20080269347A1 (en) 2006-09-28 2008-10-30 Azopharma, Inc. Epinephrine formulations
US8628805B2 (en) 2009-06-04 2014-01-14 Alk Ag Stabilized composition comprising at least one adrenergic compound

Similar Documents

Publication Publication Date Title
JP2012528831A5 (cg-RX-API-DMAC7.html)
RU2011153403A (ru) Стабилизированная композиция, содержащая по меньшей мере одно адренергическое соединение
EA201200318A1 (ru) Гетероциклические оксимы
NZ609719A (en) Pharmaceutical composition
EA201270666A1 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
EA201200260A1 (ru) Гетероциклические гидразоны и их применение для лечения рака и воспаления
EA201691242A1 (ru) Фармацевтические композиции, содержащие azd9291
EA201491335A1 (ru) Бигуанидные композиции и способы лечения метаболических расстройств
EA201100255A1 (ru) 5-алкинилпиримидины
EA201401231A1 (ru) Фармацевтические комбинации, предназначенные для лечения метаболических нарушений
EA201100254A1 (ru) Новые соединения
RU2016147362A (ru) Препараты жидкого концетрата циклофосфамида
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
CY1111460T1 (el) Μεθανοσουλφονικη 4-[(3-φθοροφαινοξυ) φαινυλο-μεθυλο] πιπεριδινη: χρησεις, διεργασια συνθεσης και φαρμακευτικες συνθεσεις
WO2018160178A8 (en) Pharmaceutically acceptable salts of b-guanidinopropionic acid with improved properties and uses thereof
EA201490166A1 (ru) Фторированные арилалкиламинокарбоксамидные производные
RU2014114512A (ru) Водные композиции, содержащие арбекацин
RU2008127882A (ru) Лечение пищевода барретта
EA201101517A1 (ru) 5-алкинилпиридины
DK1735296T3 (da) Materialer og fremgangsmåder til behandling af koagulationslidelser
EA201100916A1 (ru) Комбинация инсулина с триазиновыми производными и их применение для лечения диабета
EA201100502A1 (ru) Гликозидные производные и их применения
RU2015100116A (ru) Тигециклиновая композиция для инъекции
HRP20110459T1 (hr) Upotreba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju ozljeda kralježnične moždine
NZ592378A (en) Choline and tromethamine salt of licofelone